Ligand validation:8C9Y

EVB: sulfonato-calix[8]arene

EVB is a Ligand Of Interest in 8C9Y designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8C9Y_EVB_A_101	94%	93%	0.079	0.978	0.28	0.22	-	-	0	0	100%	0.5
8C9Y_EVB_A_102	54%	91%	0.143	0.909	0.36	0.2	-	-	0	0	100%	0.675
8Q6B_EVB_A_104	92%	92%	0.079	0.97	0.28	0.24	-	-	0	0	100%	1
6Z5X_EVB_A_101	87%	88%	0.09	0.961	0.33	0.33	-	1	1	0	100%	1
6Z60_EVB_A_101	81%	86%	0.094	0.947	0.34	0.37	-	1	0	0	100%	1
6Z5W_EVB_A_101	78%	85%	0.108	0.95	0.38	0.36	-	1	0	0	100%	1
6STH_EVB_A_104	76%	23%	0.104	0.94	2.22	1	31	7	1	0	100%	1
6GD7_EVB_A_202	96%	24%	0.065	0.975	2	1.11	8	10	0	0	100%	1
6GD6_EVB_A_202	90%	30%	0.086	0.968	1.71	1.11	9	10	0	0	100%	1
6HAJ_EVB_B_101	90%	25%	0.07	0.951	1.96	1.14	8	14	0	0	100%	1
6GD8_EVB_A_202	85%	22%	0.112	0.977	2.25	1	8	10	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.